- Nichole Harper
- 04 Feb, 2013
- New York City
Stocks opened lower after a rally that lifted indexes to five-year highs last week. European markets weakness weighed heavily on the market sentiment after index in Spain and Italy dropped 2%.
- Hiruki Nakamura
- 04 Feb, 2013
- New York City
Stocks in Tokyo extended gains of the longest rally in last fifty years on the international economic data. The yen weakened more as the government, central and pension fund work in concert to debase the currency.
- Marcus Jacob
- 04 Feb, 2013
- New York City
Australian stocks eased for the second day in a row ahead of rate announcement from Reserve Bank of Australia tomorrow. Stocks were also under pressure after the home building approvals declined 4.4% in January. Transurban and Cochlear are set to release earnings tomorrow.
- Mukesh Buch
- 04 Feb, 2013
- New York City
Adani Enterprises third quarter net increased 2.2% and Bank of Baroda net declined 21.6%. Berger Paints net surged 56.4%. Hero MotoCorp January total sales climbed 7%. Indian Bank net tumbled 37.1%. IL&FS Transportation net jumped 18.6% and Rural Electrification net surged 33.4%.
- Bikram Pandey
- 01 Feb, 2013
- New York City
Market indexes on Wall Street gained more than 1% and extended gains for the year. The S&P 500 index added 0.6% in the week and added 6.1% in the year so far on the strength in manufacturing and construction industry. World markets gained and the euro advanced to a 14-month high.
- Barry Randall
- 01 Feb, 2013
- New York City
BT Group soared 7% after it reported higher than expected adjusted operating earnings. Banca Popolare di Milano may restructure as a joint stock company. Stocks in Madrid declined after financial regulator lifted a ban on short selling. Tate & Lyle fell on sucralose sales outlook.
- Barry Randall
- 01 Feb, 2013
- New York City
European markets rebounded at the fastest pace in three weeks after latest economic data in the region indicated improved manufacturing sector. The data in China and U.S. also supported optimism. Spanish index dropped 1.7% after a regulator lifted short selling ban.
- Nichole Harper
- 01 Feb, 2013
- New York City
Stocks and indexes traded higher after employers added 157,000 jobs in January. Job additions data in November and December were revised higher and employers added 181,000 jobs a month in 2012.
- Mukesh Buch
- 01 Feb, 2013
- New York City
Aon fourth quarter net soared 10% and Chevron net soared 41%. Exxon Mobil fourth quarter net climbed 6% and Ingersoll-Rand net slipped 3%. Lear net surged more than seven-fold. Merck fourth quarter net declined 7% and Mattel net plunged 17%.
- Hiruki Nakamura
- 01 Feb, 2013
- New York City
The Nikkei index added 0.5% and capped weekly gain of 2.6% and extended gains for the 12th week in a row. The yen declined to the low last seen in June 2010. Softbank reported third quarter net doubled. NEC soared 9% swung to a quarterly profit.
- Marcus Jacob
- 01 Feb, 2013
- New York City
Australian markets extended gains after advancing nearly 5% in January. The latest manufacturing data from China indicated slower than expected improvement.
- Mukesh Buch
- 01 Feb, 2013
- New York City
Bhel third quarter net declined 18%. Jet Airways swung to Rs 85 crore net income. Marico net jumped 21%. MRPL net swung to a loss. M&M, Maruti Suzuki, TVS January sales slipped.
- Bikram Pandey
- 31 Jan, 2013
- New York City
U.S. stocks trimmed the gains but extended 2012 advances in January. The S&P 500 index gained 5% and has now doubled from its low in 2009. The euro closed at a 14-month high and markets in Japan surged 7% on the stimulus hopes.
- Barry Randall
- 31 Jan, 2013
- New York City
AstraZeneca fell after it estimated lower sales in the current year. Deutsche Bank reported a loss and Banco Santander estimated higher loan losses in Spain. Ericsson reported sales increased 5%. Infineon forecasted higher sales and operating earnings. Lonmin soared on 17% rise in platinum sales.
- Barry Randall
- 31 Jan, 2013
- New York City
Markets in the euro zone declined after weaker than expected earnings and German retail sales fell in December. AstraZeneca estimated sales decline on higher competition from generics. Banco Santander set aside more capital cover losses in Spanish loans. Deutsche Bank reported a loss.